Journalist and writer. Currently a Bloomberg reporter in London via Hong Kong, New York, Sydney. Previously freelanced for IHT, NYT in Paris. Opinions my own.
Finland's Neste has attracted more attention from short sellers than any other oil stock in Europe’s benchmark equity index, a sign of how high the stakes are when the company faces investors this week bloomberg.com/news/articles/…@markets@lisapham
Novo Nordisk has fallen behind Eli Lilly this year in the race to be the big stock market winner from obesity drugs. Analysts expect the Danish company to start catching up bloomberg.com/news/articles/… via @markets@lisapham
Amid the frenzy surrounding weight-loss medicines, one biotech company is rewarding investors by focusing on a much more low-profile area of drug development bloomberg.com/news/articles/… via @markets@lisapham
Positive results in the earliest stages of development have driven about $93 billion in market value gains this year for obesity-drug makers, according to Bloomberg calculations bloomberg.com/news/articles/… via @business@naomikresge@lisapham
To deliver what could be one of the UK’s biggest-ever IPOs, Shein will need to win over politicians and investors. Critics point to ESG concerns, including allegations the firm’s products are linked to forced labor bloomberg.com/news/articles/… via @markets@lisapham@WilliamShaw546
After the 2% IPO story - here's a follow up from @lisapham & @marketsjoe on what difference the government’s proposal for a tax-free savings account would mean to the UK in terms of flows bloomberg.com/news/articles/… via @markets
Pre-close calls with analysts have been a tradition in markets for years. Some investors say the practice needs to change. bloomberg.com/news/articles/… via @business
Jeremy Hunt is likely to turn to retail investors in an attempt to save the UK market.
But one version of UK ISA winning support may cost taxpayers thousands of pounds - stripping out tax relief on overseas firms.
With @lisapham and @marketsjoebloomberg.com/news/articles/…
NEW: What is the Ozempic & Zepboud effect on the financial markets? Drugmaker Eli Lilly ($LLY) has exceeded Tesla ($TSLA) in market value, and some say the stock should be added to the Magnificent 7 index that also includes Nvidia ($NVDA) @lisapham reports bloomberg.com/news/articles/…
Short-seller Hindenburg made a splash when it took on India's richest man. Now, it's targeting Jack Dorsey's Block.
@lisapham tells you what you need to know about short selling trib.al/icwV14i
Ever wanted an easy way to
understand how the put option deals beloved by Mike Ashley’s Frasers work? Then listen to the excellent @lisapham explain the ins and outs of it all at her local garden centre. (Reason #1305 to love a garden centre too!)